Loading clinical trials...
Loading clinical trials...
To demonstrate that use of the Sentinel® Cerebral Protection System significantly reduces the risk of peri-procedural stroke (≤72 hours) after transcatheter aortic valve replacement (TAVR).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Boston Scientific Corporation
NCT07641790 · Hemiplegia, Stroke
NCT06682429 · Stroke
NCT07441382 · Atrial Fibrillation (AF), Stroke, and more
NCT07610850 · Stroke, Hemiplegia
NCT07631078 · Stroke, Chronic Stroke Patients, and more
Tucson Medical Center
Tucson, Arizona
Cedars Sinai Medical Center
Los Angeles, California
University of California, Davis Medical Center
Sacramento, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions